Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
OliX Pharmaceuticals
company
About
OliX is a clinical stage biotechnology company.
- 51 - 100
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- ₩41.50B
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Feb 26, 2010
- Number Of Employee
- 51 - 100
- Operating Status
- Active
OliX is a clinical stage biotechnology company, based on their own proprietary RNA interference (RNAi) technology regulating the expression of disease-causing genes.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
₩41.50B
OliX Pharmaceuticals has raised a total of
₩41.50B
in funding over 2 rounds. Their latest funding was raised on
Dec 1, 2020 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 1, 2020 | Post-IPO Equity | ₩41.50B | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
OliX Pharmaceuticals is funded by 1 investors.
Widwin Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Widwin Investment
|
— | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
